Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 7 May 2009, Vol. 113, No. 19, pp. 4566-4574.
Prepublished online as a Blood First Edition Paper on February 5, 2009; DOI 10.1182/blood-2008-08-176057.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
blood-2008-08-176057v1
113/19/4566    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schuman, J.
Right arrow Articles by Wang, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schuman, J.
Right arrow Articles by Wang, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted August 27, 2008
Accepted February 2, 2009

A critical role of TAK1 in B cell receptor-mediated NF-{kappa}B activation

James Schuman, Yuhong Chen, Andrew Podd, Mei Yu, Hong-Hsing Liu, Renren Wen, Zhijian J. Chen, and Demin Wang*

Blood Research Institute, the BloodCenter of Wisconsin, Milwaukee, WI, United States
Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, WI, United States
State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China
Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, United States
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, United States

* Corresponding author; email: demin.wang{at}bcw.edu.

The kinase TAK1 is essential for T cell receptor (TCR)-mediated NF-{kappa}B activation and T cell development. However, the role of TAK1 in B cell receptor (BCR)-mediated NF-{kappa}B activation and B cell development is not clear. Here we show that B cell-specific deletion of TAK1 impaired the transition from transitional type 2 to mature follicular (FO) B cells and caused a marked decrease of marginal zone (MZ) B cells. TAK1-deficient B cells exhibited an increase of BCR-induced apoptosis and impaired proliferation in response to BCR ligation. Importantly, TAK1-deficient B cells failed to activate NF-{kappa}B following BCR stimulation. Thus, TAK1 is critical for B cell maturation and BCR-induced NF-{kappa}B activation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020